In BRAF-mutated melanoma, the inhibition of BRAF and MEK proteins enhances the expression of melanocyte-differentiation antigens, the upregulation of proinflammatory cytokines, the downregulation of anti-inflammatory cytokines, the expression of PDL1 and the infiltration of the tumor by CD8+ T-cells [75]. The gene discussed is CD274; the disease is melanoma.